| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Thaninee Prasoppokakorn, Palakorn Panara. First Case of Esophagitis Dissecans Superficialis in an HIV Patient: A Case Report and Literature Review. Case reports in infectious diseases. vol 2019. 2020-09-30. PMID:31355025. |
however, his symptom of dysphagia was not explained by eds, but was the early symptoms of muscle-specific kinase (musk) myasthenia gravis (mg) that we finally diagnosed later by progression of the symptoms and electrophysiologic study. |
2020-09-30 |
2023-08-13 |
Not clear |
| Thaninee Prasoppokakorn, Palakorn Panara. First Case of Esophagitis Dissecans Superficialis in an HIV Patient: A Case Report and Literature Review. Case reports in infectious diseases. vol 2019. 2020-09-30. PMID:31355025. |
this is the first case of eds and musk myasthenia gravis in an hiv-infected patient. |
2020-09-30 |
2023-08-13 |
Not clear |
| Fu Liong Hie. Grave Prognosis of the MuscleSpecific Kinase (MuSK)-positive Myasthenia Gravis (MG): A False Prejudice. Annals of Indian Academy of Neurology. vol 23. issue 1. 2020-09-28. PMID:32055112. |
grave prognosis of the musclespecific kinase (musk)-positive myasthenia gravis (mg): a false prejudice. |
2020-09-28 |
2023-08-13 |
Not clear |
| Ken-Ichi Inoue, Jun Tsugawa, Jiro Fukae, Kosuke Fukuhara, Hiroyasu Kawano, Shinsuke Fujioka, Yoshio Tsubo. Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature. Case reports in neurology. vol 12. issue 1. 2020-09-28. PMID:32308606. |
because of her myasthenic symptoms and anti-muscle-specific tyrosine kinase (musk) antibody (ab)-positive status, she was diagnosed as having myasthenia gravis (mg). |
2020-09-28 |
2023-08-13 |
Not clear |
| Carmelo Rodolico, Carmen Bonanno, Antonio Toscano, Giuseppe Vit. MuSK-Associated Myasthenia Gravis: Clinical Features and Management. Frontiers in neurology. vol 11. 2020-09-28. PMID:32793097. |
muscle-specific tyrosine kinase (musk) myasthenia gravis (mg) is a rare, frequently more severe, subtype of mg with different pathogenesis, and peculiar clinical features. |
2020-09-28 |
2023-08-13 |
Not clear |
| Maartje G Huijbers, Dana L Vergoossen, Yvonne E Fillié-Grijpma, Inge E van Es, Marvyn T Koning, Linda M Slot, Hendrik Veelken, Jaap J Plomp, Silvère M van der Maarel, Jan J Verschuure. MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity. Neurology(R) neuroimmunology & neuroinflammation. vol 6. issue 3. 2020-09-24. PMID:30882021. |
musk myasthenia gravis monoclonal antibodies: valency dictates pathogenicity. |
2020-09-24 |
2023-08-13 |
Not clear |
| Maartje G Huijbers, Dana L Vergoossen, Yvonne E Fillié-Grijpma, Inge E van Es, Marvyn T Koning, Linda M Slot, Hendrik Veelken, Jaap J Plomp, Silvère M van der Maarel, Jan J Verschuure. MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity. Neurology(R) neuroimmunology & neuroinflammation. vol 6. issue 3. 2020-09-24. PMID:30882021. |
to isolate and characterize muscle-specific kinase (musk) monoclonal antibodies from patients with musk myasthenia gravis (mg) on a genetic and functional level. |
2020-09-24 |
2023-08-13 |
Not clear |
| Konstantinos Lazaridis, Vasiliki Baltatzidou, Nikolaos Tektonidis, Socrates J Tzarto. Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis. Journal of neuroimmunology. vol 339. 2020-07-09. PMID:31855721. |
antigen-specific immunoadsorption of musk autoantibodies as a treatment of musk-induced experimental autoimmune myasthenia gravis. |
2020-07-09 |
2023-08-13 |
human |
| Liis Sabre, Amelia Evoli, Anna Rostedt Pung. Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis. Journal of the neurological sciences. vol 399. 2020-06-18. PMID:30738333. |
cognitive dysfunction in mice with passively induced musk antibody seropositive myasthenia gravis. |
2020-06-18 |
2023-08-13 |
mouse |
| Jiaojiao Han, Jing Zhang, Mingqiang Li, Yingna Zhang, Jie Lv, Xue Zhao, Shumin Wang, Lulu Wang, Haonan Yang, Sensen Han, Hua Fang, Feng Ga. A novel MuSK cell-based myasthenia gravis diagnostic assay. Journal of neuroimmunology. vol 337. 2020-06-17. PMID:31655425. |
a novel musk cell-based myasthenia gravis diagnostic assay. |
2020-06-17 |
2023-08-13 |
Not clear |
| M Çebi, H Durmuş, V Yılmaz, S P Yentür, F Aysal, P Oflazer, Y Parman, F Deymeer, G Saruhan-Direskenel. Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG). Clinical and experimental immunology. vol 197. issue 2. 2020-04-21. PMID:30929252. |
a small subset of myasthenia gravis (mg) patients develop autoantibodies against muscle-specific kinase (musk), which are predominantly of the immunoglobulin (ig)g4 isotype. |
2020-04-21 |
2023-08-13 |
Not clear |
| Maartje G Huijbers, Jaap J Plomp, Inge E van Es, Yvonne E Fillié-Grijpma, Samar Kamar-Al Majidi, Peter Ulrichts, Hans de Haard, Erik Hofman, Silvère M van der Maarel, Jan J Verschuure. Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis. Experimental neurology. vol 317. 2020-02-26. PMID:30851266. |
we therefore tested efgartigimod (argx-113), a new neonatal fc receptor blocker, in a mouse model for musk myasthenia gravis. |
2020-02-26 |
2023-08-13 |
mouse |
| Maartje G Huijbers, Jaap J Plomp, Inge E van Es, Yvonne E Fillié-Grijpma, Samar Kamar-Al Majidi, Peter Ulrichts, Hans de Haard, Erik Hofman, Silvère M van der Maarel, Jan J Verschuure. Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis. Experimental neurology. vol 317. 2020-02-26. PMID:30851266. |
this model involves 11 daily injections of purified igg4 from musk myasthenia gravis patients, resulting in overt myasthenic muscle weakness and, consequently, body weight loss. |
2020-02-26 |
2023-08-13 |
mouse |
| Maartje G Huijbers, Jaap J Plomp, Inge E van Es, Yvonne E Fillié-Grijpma, Samar Kamar-Al Majidi, Peter Ulrichts, Hans de Haard, Erik Hofman, Silvère M van der Maarel, Jan J Verschuure. Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis. Experimental neurology. vol 317. 2020-02-26. PMID:30851266. |
in conclusion, our study shows that efgartigimod has clear therapeutic potential in musk myasthenia gravis and forms an exciting candidate drug for many autoantibody-mediated neurological and other disorders. |
2020-02-26 |
2023-08-13 |
mouse |
| Amena Usmani, Laura Kwan, Dina Wahib-Khalil, Jaya Trivedi, Sharon Nations, Ravi Sarod. Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status. Journal of clinical apheresis. vol 34. issue 4. 2020-01-15. PMID:30779438. |
the primary objective of this study was to assess response to plasma exchange (plex) in myasthenia gravis (mg) patients with and without autoantibodies (ab) to acetylcholine receptor (achr) or muscle-specific kinase (musk). |
2020-01-15 |
2023-08-13 |
Not clear |
| James D Triplett, Todd A Hardy, D Sean Riminton, Shannon Y K Chu, Stephen W Redde. Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse? Muscle & nerve. vol 60. issue 3. 2020-01-09. PMID:31177576. |
association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: a marker of relapse? |
2020-01-09 |
2023-08-13 |
Not clear |
| James D Triplett, Todd A Hardy, D Sean Riminton, Shannon Y K Chu, Stephen W Redde. Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse? Muscle & nerve. vol 60. issue 3. 2020-01-09. PMID:31177576. |
muscle-specific tyrosine kinase (musk) autoantibody related myasthenia gravis is characterized by bulbar and respiratory manifestations, a poor response to anticholinergics, and a generally good response to plasma exchange and rituximab. |
2020-01-09 |
2023-08-13 |
Not clear |
| Elena Cortés-Vicente, Ricard Rojas-Garcia, Jordi Díaz-Manera, Luis Querol, Carlos Casasnovas, Antonio Guerrero-Sola, José Luis Muñoz-Blanco, José Eulalio Bárcena-Llona, Celedonio Márquez-Infante, Julio Pardo, Eva María Martínez-Fernández, Mercedes Usón, Pedro Oliva-Nacarino, Teresa Sevilla, Isabel Ill. The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis. Annals of clinical and translational neurology. vol 5. issue 6. 2019-11-20. PMID:29928654. |
to evaluate whether the clinical benefit and relapse rates in anti-muscle-specific kinase (musk) myasthenia gravis (mg) differ depending on the protocol of rituximab followed. |
2019-11-20 |
2023-08-13 |
Not clear |
| Ernestina Santos, Antonio Braga, Denis Gabriel, Sara Duarte, Ana Martins da Silva, Ilda Matos, Marta Freijo, Joao Martins, Fernando Silveira, Goreti Nadais, Filipa Sousa, Carla Fraga, Rosa Santos Silva, Carlos Lopes, Guilherme Gonçalves, Clara Pinto, Jorge Sousa Braga, Maria Isabel Leit. MuSK myasthenia gravis and pregnancy. Neuromuscular disorders : NMD. vol 28. issue 2. 2019-11-14. PMID:29305138. |
musk myasthenia gravis and pregnancy. |
2019-11-14 |
2023-08-13 |
Not clear |
| Ernestina Santos, Antonio Braga, Denis Gabriel, Sara Duarte, Ana Martins da Silva, Ilda Matos, Marta Freijo, Joao Martins, Fernando Silveira, Goreti Nadais, Filipa Sousa, Carla Fraga, Rosa Santos Silva, Carlos Lopes, Guilherme Gonçalves, Clara Pinto, Jorge Sousa Braga, Maria Isabel Leit. MuSK myasthenia gravis and pregnancy. Neuromuscular disorders : NMD. vol 28. issue 2. 2019-11-14. PMID:29305138. |
muscle specific kinase (musk) myasthenia gravis (mg, musk-mg) is a rare subgroup of mg affecting mainly women during childbearing years. |
2019-11-14 |
2023-08-13 |
Not clear |